Melanotan 2: Benefits and Applications
MELANOTAN II 10mg 
 
Introduction
Melanotan 2 is a synthetic peptide designed to mimic alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring substance secreted by the pituitary gland. α-MSH plays a crucial role in regulating various bodily functions by binding to melanocortin receptors. There are five types of these receptors, each affecting the body differently, including melanin production for skin and hair pigmentation, appetite regulation, and sexual behavior.
 
Benefits of Melanotan 2
 
Enhanced Tanning and Skin Protection Melanotan 2 has shown the ability to induce tanning and increase skin pigmentation while reducing the risk of sunburn and UV damage. Some studies even suggest that Melanotan 2 may provide added protection against skin cancer [3, 4, 5].
Appetite Regulation and Fat Reduction Research indicates that Melanotan 2 can influence appetite regulation, leading to reduced fat storage and a shift in food preferences away from high-fat foods [6, 7, 8].
Blood Sugar Regulation Preliminary studies suggest that Melanotan 2 might play a role in regulating blood sugar levels, which could have implications for managing glycemic control [9].
Improved Impulse Control and Addictive Behavior Animal studies have found that Melanotan 2 may help regulate impulsive behavior, pointing to potential benefits in managing addictive behaviors [10].
Increased Libido and Enhanced Sexual Function Melanotan 2 has been associated with increased libido and improved sexual function, originally developed to address hypoactive sexual desire in both males and females [11, 12].
 
Side Effects
The observed side effects of Melanotan 2 include yawning, stretching, reduced appetite, increased sexual arousal, darkening of facial hair and moles, flushing, nausea, lethargy, and dizziness [13]. Despite these effects, research reviews generally consider the side effects to be minor [13].
 
Conclusion
Although Melanotan 2 is not FDA-approved, initial research highlights several potential effects that warrant further exploration. Researchers interested in these effects should review previous clinical studies to understand dosing and outcomes.
 
References
Plant, T. M., & Zeleznik, A. J. (2014). Knobil and Neill's Physiology of Reproduction: Two-Volume Set. Academic Press.
King, S. H., et al. (2007). Melanocortin receptors, melanotropic peptides, and penile erection. Current Topics in Medicinal Chemistry, 7(11), 1111-1119.
Brennan, R., et al. (2014). An unhealthy glow? A review of melanotan use and associated clinical outcomes. Performance Enhancement & Health, 3(2), 78–92.
Barnetson, R. S., et al. (2006). [Nle4-D-Phe7]-α-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers. Journal of Investigative Dermatology, 126(8), 1869-1878.
FitzGerald, L. M., et al. (2006). Effect of MELANOTAN®, [Nle4, D-Phe7]-α-MSH, on melanin synthesis in humans with MC1R variant alleles. Peptides, 27(2), 388-394.
van der Klaauw, A., et al. (2015). Role of melanocortin signalling in the preference for dietary macronutrients in human beings. The Lancet, 385, S12.
Lee, Y. S. (2009). The role of leptin-melanocortin system and human weight regulation: lessons from experiments of nature. Annals Academy of Medicine Singapore, 38(1), 34.
Bjørbæk, C., & Hollenberg, A. N. (2002). Leptin and melanocortin signaling in the hypothalamus. Vitamins and Hormones, 65, 281-311.
Guo, F., et al. (2004). Leptin signaling targets the thyrotropin-releasing hormone gene promoter in vivo. Endocrinology, 145(5), 2221-2227.
York, D. A., et al. (2011). Melanocortin activity in the amygdala influences alcohol intake. Pharmacology Biochemistry and Behavior, 98(1), 112-119.
Wessells, H., et al. (1998). Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. The Journal of Urology, 160(2), 389-393.
Hakim, L. S. (1998). Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: Double-blind placebo controlled crossover study. International Journal of Impotence Research, 10(4), 263-263.
Brennan, R., et al. (2014). An unhealthy glow? A review of melanotan use and associated clinical outcomes. Performance Enhancement & Health, 3(2), 78-92.